rs146163970

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP6

The NM_005198.5(CHKB):​c.263C>T​(p.Pro88Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000233 in 1,583,094 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P88A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00025 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00023 ( 1 hom. )

Consequence

CHKB
NM_005198.5 missense

Scores

6
8
5

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: 7.58

Publications

3 publications found
Variant links:
Genes affected
CHKB (HGNC:1938): (choline kinase beta) Choline kinase (CK) and ethanolamine kinase (EK) catalyze the phosphorylation of choline/ethanolamine to phosphocholine/phosphoethanolamine. This is the first enzyme in the biosynthesis of phosphatidylcholine/phosphatidylethanolamine in all animal cells. The highly purified CKs from mammalian sources and their recombinant gene products have been shown to have EK activity also, indicating that both activities reside on the same protein. The choline kinase-like protein encoded by CHKL belongs to the choline/ethanolamine kinase family; however, its exact function is not known. Read-through transcripts are expressed from this locus that include exons from the downstream CPT1B locus. [provided by RefSeq, Jun 2009]
CHKB-CPT1B (HGNC:41998): (CHKB-CPT1B readthrough (NMD candidate)) The genes CHKB and CPT1B are adjacent on chromosome 22 and read-through transcripts are expressed that include exons from both loci. The read-through transcripts are candidates for nonsense-mediated mRNA decay (NMD) and are unlikely to express proteins. [provided by RefSeq, Jun 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

BP6
Variant 22-50582319-G-A is Benign according to our data. Variant chr22-50582319-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 447030.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CHKBNM_005198.5 linkc.263C>T p.Pro88Leu missense_variant Exon 2 of 11 ENST00000406938.3 NP_005189.2
CHKB-CPT1BNR_027928.2 linkn.481C>T non_coding_transcript_exon_variant Exon 2 of 30

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CHKBENST00000406938.3 linkc.263C>T p.Pro88Leu missense_variant Exon 2 of 11 1 NM_005198.5 ENSP00000384400.3

Frequencies

GnomAD3 genomes
AF:
0.000250
AC:
38
AN:
152148
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00259
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000620
Gnomad FIN
AF:
0.0000943
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000338
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000296
AC:
58
AN:
196110
AF XY:
0.000394
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00314
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000178
Gnomad OTH exome
AF:
0.000397
GnomAD4 exome
AF:
0.000231
AC:
331
AN:
1430946
Hom.:
1
Cov.:
32
AF XY:
0.000258
AC XY:
183
AN XY:
709234
show subpopulations
African (AFR)
AF:
0.0000303
AC:
1
AN:
32986
American (AMR)
AF:
0.0000248
AC:
1
AN:
40382
Ashkenazi Jewish (ASJ)
AF:
0.00377
AC:
96
AN:
25472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38424
South Asian (SAS)
AF:
0.000441
AC:
36
AN:
81710
European-Finnish (FIN)
AF:
0.000325
AC:
16
AN:
49198
Middle Eastern (MID)
AF:
0.000232
AC:
1
AN:
4308
European-Non Finnish (NFE)
AF:
0.000150
AC:
165
AN:
1099340
Other (OTH)
AF:
0.000254
AC:
15
AN:
59126
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
17
34
52
69
86
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000250
AC:
38
AN:
152148
Hom.:
0
Cov.:
33
AF XY:
0.000256
AC XY:
19
AN XY:
74322
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41450
American (AMR)
AF:
0.0000654
AC:
1
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00259
AC:
9
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.000620
AC:
3
AN:
4836
European-Finnish (FIN)
AF:
0.0000943
AC:
1
AN:
10610
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000338
AC:
23
AN:
68008
Other (OTH)
AF:
0.00
AC:
0
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000532
Hom.:
0
Bravo
AF:
0.000223
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000468
AC:
4
ExAC
AF:
0.000202
AC:
24
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:2
Jun 07, 2016
Athena Diagnostics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 18, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: CHKB c.263C>T (p.Pro88Leu) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.0003 in 196110 control chromosomes. c.263C>T has been reported in the literature in two siblings with Proximal Myopathy (Brady_2016). These report(s) do not provide unequivocal conclusions about association of the variant with Megaconial Type Congenital Muscular Dystrophy. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 26782016). ClinVar contains an entry for this variant (Variation ID: 447030). Based on the evidence outlined above, the variant was classified as uncertain significance. -

Megaconial type congenital muscular dystrophy Benign:1
Oct 10, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.37
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Benign
-0.22
CADD
Pathogenic
30
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.63
D
Eigen
Pathogenic
0.79
Eigen_PC
Pathogenic
0.77
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.93
D
M_CAP
Pathogenic
0.58
D
MetaRNN
Uncertain
0.55
D
MetaSVM
Benign
-0.41
T
MutationAssessor
Uncertain
2.7
M
PhyloP100
7.6
PrimateAI
Pathogenic
0.84
D
PROVEAN
Pathogenic
-8.3
D
REVEL
Uncertain
0.38
Sift
Benign
0.039
D
Sift4G
Uncertain
0.036
D
Polyphen
1.0
D
Vest4
0.90
MVP
0.92
ClinPred
0.36
T
GERP RS
5.1
Varity_R
0.88
gMVP
0.79
Mutation Taster
=17/83
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146163970; hg19: chr22-51020748; API